Dutch Medical Food B.V., a leader in medical nutrition, has partnered with Pristine Pearl Pharma Pvt. Ltd. to introduce advanced nutritional products for respiratory diseases at NAPCON 2024, India’s National Pulmonary Conference.
The products focus on helping patients with Chronic Obstructive Pulmonary Disease (COPD) and related respiratory conditions. With nearly 55.3 million Indians affected by COPD, the disease is a leading cause of disability and mortality, often worsened by severe malnutrition. Malnutrition in COPD patients leads to muscle loss, reduced energy, and poor recovery.
“Respiratory conditions like COPD often cause serious nutritional deficiencies that delay recovery,” said Dr. Guru Ramanathan, Co-founder of Dutch Medical Food. “Our products aim to address these gaps, complementing standard treatments.”
This launch represents a significant step in personalized nutrition, offering healthcare professionals effective tools to integrate nutrition into patient care. “We are equipping India’s healthcare system with evidence-based solutions tailored for Indian needs,” said Dr. Rolf Smeets, Co-founder of Dutch Medical Food.
The collaboration leverages Dutch Medical Food’s expertise and Pristine Pearl’s understanding of the Indian healthcare landscape. “Our mission is to provide high-quality nutritional products to improve patient outcomes across India,” added Mr. S.M. Ayoob, Managing Director of Pristine Pearl Pharma. This initiative marks a new milestone in managing disease-related malnutrition.
